5’-O-DMTr-N6-Fmoc-dA-phosphoramidite 10 mg | ≥95% Cayman Chemical A nucleoside building block More Information Supplier Page × 5’-O-DMTr-N6-Fmoc-dA-phosphoramidite
5’-O-DMTr-N6-Fmoc-dA-phosphoramidite 1 mg | ≥95% Cayman Chemical A nucleoside building block More Information Supplier Page × 5’-O-DMTr-N6-Fmoc-dA-phosphoramidite
5-Me-3’-dU-2’-phosphoramidite 50 mg | ≥98% Cayman Chemical A nucleoside building block More Information Supplier Page × 5-Me-3’-dU-2’-phosphoramidite
5-Me-3’-dU-2’-phosphoramidite 25 mg | ≥98% Cayman Chemical A nucleoside building block More Information Supplier Page × 5-Me-3’-dU-2’-phosphoramidite
5-Me-3’-dU-2’-phosphoramidite 100 mg | ≥98% Cayman Chemical A nucleoside building block More Information Supplier Page × 5-Me-3’-dU-2’-phosphoramidite
5-Me-3’-dU-2’-phosphoramidite 10 mg | ≥98% Cayman Chemical A nucleoside building block More Information Supplier Page × 5-Me-3’-dU-2’-phosphoramidite
GSK3β Inhibitor 2 5 mg | ≥95% Cayman Chemical A GSK3ß inhibitor More Information Supplier Page × GSK3β Inhibitor 2
GSK3β Inhibitor 2 25 mg | ≥95% Cayman Chemical A GSK3ß inhibitor More Information Supplier Page × GSK3β Inhibitor 2
GSK3β Inhibitor 2 10 mg | ≥95% Cayman Chemical A GSK3ß inhibitor More Information Supplier Page × GSK3β Inhibitor 2
GSK3β Inhibitor 2 1 mg | ≥95% Cayman Chemical A GSK3ß inhibitor More Information Supplier Page × GSK3β Inhibitor 2
